Submitted for Publication: January 3, 2015; final revision received January 3, 2015; accepted January 20, 2015.
Published Online: March 18, 2015. doi:10.1001/jamapsychiatry.2015.0071.
Study concept and design: Kaiser, Wager, Pizzagalli.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Kaiser, Andrews-Hanna.
Critical revision of the manuscript: All authors.
Statistical analysis: Kaiser, Andrews-Hanna, Wager.
Obtained funding: Kaiser, Pizzagalli.
Administrative, technical, or material support: Andrews-Hanna, Pizzagalli.
Study supervision: Wager, Pizzagalli.
Conflict of Interest Disclosures: Dr Pizzagalli has reported receiving honoraria and consulting fees from Advanced Neuro Technology North America, AstraZeneca, Otsuka Pharmaceutical, Pfizer, and Servier for activities unrelated to this project. No other disclosures were reported.
Funding/Support: This project was partially supported by grants R01 MH068376 and R01 MH101521 (Dr Pizzagalli), R01 MH101521 (Drs Wager and Andrews-Hanna), and R01 MH076136 (Drs Wager and Andrews-Hanna) from the National Institute of Mental Health and by The Phyllis and Jerome Lyle Rappaport Mental Health Research Fellowship (McLean Hospital) (Dr Kaiser).
Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.
Additional Contributions: Franziska Goer, BA, Center for Depression, Anxiety, and Stress Research, McLean Hospital, Belmont, Massachusetts, provided interrater checks on the database. No compensation was provided. We thank the authors of the included studies, with special thanks to authors who generously shared unpublished data from whole-brain analyses and seed ROI and peak coordinates for inclusion in this meta-analysis.